(Q39215441)

10 September 2017

title

Deferiprone or deferoxamine vs. combination therapy in patients with beta-thalassemia major: a case study in Taiwan (English)

1 reference

10 September 2017

main subject

beta-thalassemia major

1 reference

1 reference

Kang-Hsi Wu

2

1 reference

ORCID Public Data File 2021

author name string

Ching-Tien Peng

1

1 reference

10 September 2017

Shu-Fen Wu

3

1 reference

10 September 2017

Der-Cherng Liang

4

1 reference

10 September 2017

Chao-Ping Yang

5

1 reference

10 September 2017

Ren-Chin Jang

6

1 reference

10 September 2017

Lin-Yen Wang

7

1 reference

10 September 2017

Chih-Cheng Hsiao

8

1 reference

10 September 2017

publication date

1 January 2006

1 reference

10 September 2017

1 reference

10 September 2017

volume

30

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

125-130

1 reference

Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

Role of deferiprone in chelation therapy for transfusional iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260500455581

10.1080/03630260500455581

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference